HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tjasa Hranjec Selected Research

Wounds and Injuries (Trauma)

5/2014Sex- and diagnosis-dependent differences in mortality and admission cytokine levels among patients admitted for intensive care.
2/2013Improvements in pulmonary and general critical care reduces mortality following ventilator-associated pneumonia.
10/2012Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study.
10/2011Effective cohorting and "superisolation" in a single intensive care unit in response to an outbreak of diverse multi-drug-resistant organisms.
5/2010Diagnosis-dependent relationships between cytokine levels and survival in patients admitted for surgical critical care.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tjasa Hranjec Research Topics

Disease

18Infections
03/2020 - 04/2010
9Critical Illness (Critically Ill)
12/2020 - 05/2010
5Wounds and Injuries (Trauma)
05/2014 - 05/2010
3Intraabdominal Infections
08/2015 - 07/2011
2Acute Kidney Injury (Acute Renal Failure)
12/2020 - 08/2013
2Inflammation (Inflammations)
01/2018 - 05/2010
2Ventilator-Associated Pneumonia
10/2014 - 02/2013
2Sepsis (Septicemia)
10/2014 - 10/2013
2Pneumonia (Pneumonitis)
10/2013 - 10/2010
1Thrombocytopenia (Thrombopenia)
12/2020
1COVID-19
12/2020
1Thrombocytosis (Thrombocythemia)
12/2020
1Fistula
01/2018
1Bacteremia
08/2015
1Cross Infection (Nosocomial Infection)
10/2014
1Aspergillosis
06/2014
1Vascular Diseases (Vascular Disease)
04/2014
1Septic Shock (Toxic Shock Syndrome)
10/2013
1Chronic Kidney Failure (Chronic Renal Failure)
08/2013
1Lung Diseases (Lung Disease)
02/2013
1Hepatitis
08/2012
1Lung Injury
04/2012
1Hypercapnia
04/2012
1Burns
10/2011
1Surgical Wound Infection
07/2011
1Anastomotic Leak
07/2011
1Ischemia
10/2010
1Reperfusion Injury
10/2010
1Bronchiolitis Obliterans Syndrome
05/2010
1Coinfection
04/2010
1Fibrosis (Cirrhosis)
02/2005
1Neoplasms (Cancer)
02/2005
1Chronic Renal Insufficiency
02/2005
1Poisoning
02/2005
1Renal Insufficiency (Renal Failure)
02/2005

Drug/Important Bio-Agent (IBA)

7Anti-Bacterial Agents (Antibiotics)IBA
08/2017 - 04/2010
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2014 - 05/2010
3CytokinesIBA
05/2014 - 05/2010
2VancomycinFDA LinkGeneric
08/2015 - 11/2013
2SteroidsIBA
06/2014 - 02/2013
2Interleukin-2 (IL2)IBA
05/2014 - 05/2010
2Interleukin-8 (Interleukin 8)IBA
05/2014 - 05/2010
2Carbapenems (Carbapenem Antibiotics)IBA
10/2011 - 04/2010
2Interleukin-6 (Interleukin 6)IBA
10/2010 - 05/2010
1fibrin fragment D (D-dimer)IBA
12/2020
1C-Reactive ProteinIBA
12/2020
1Arachidonic Acid (Vitamin F)IBA
12/2020
1Adenosine Diphosphate (ADP)IBA
12/2020
1Ferritins (Ferritin)IBA
12/2020
1HemosiderinIBA
01/2018
1Glucose (Dextrose)FDA LinkGeneric
11/2014
1Proteins (Proteins, Gene)FDA Link
11/2014
1drotrecogin alfa activated (Xigris)FDA Link
10/2014
1ChlorhexidineIBA
10/2014
1InterferonsIBA
05/2014
1Interleukin-12 (IL 12)IBA
05/2014
1Linezolid (Zyvox)FDA Link
11/2013
1CreatinineIBA
11/2013
1Pharmaceutical PreparationsIBA
11/2013
1Transaminases (Aminotransferases)IBA
08/2012
1Estradiol (Delestrogen)FDA LinkGeneric
04/2011
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
10/2010
1Peroxidase (Myeloperoxidase)IBA
10/2010
1Chemotactic FactorsIBA
10/2010
1Purinergic P1 Receptors (Adenosine Receptor)IBA
10/2010
1salicylhydroxamic acid (SHAM)IBA
10/2010
1Adenosine A2B ReceptorIBA
10/2010
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
05/2010
1Interleukin-4 (Interleukin 4)IBA
05/2010
1Metronidazole (Metric)FDA LinkGeneric
04/2010
1N 30IBA
02/2005
1aristolochic acid I (aristolochic acid)IBA
02/2005

Therapy/Procedure

8Therapeutics
12/2020 - 02/2013
6Critical Care (Surgical Intensive Care)
03/2020 - 05/2010
4Length of Stay
11/2014 - 04/2012
3Lung Transplantation
08/2013 - 05/2010
2Artificial Respiration (Mechanical Ventilation)
12/2020 - 04/2012
1Nephrectomy
01/2018
1Central Venous Catheters
08/2015
1Nutritional Support (Artificial Feeding)
11/2014
1Parenteral Nutrition
11/2014
1Organ Transplantation
06/2014
1Transplantation
06/2014
1Liver Transplantation
04/2014
1Renal Dialysis (Hemodialysis)
11/2013
1Conservative Treatment
10/2012
1Extracorporeal Membrane Oxygenation
04/2012
1Operative Surgical Procedures
07/2011
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
10/2010